DISEASE TRIAL
Brain health company Ixico has agreed a £1.2m contract with a US biopharmaceutical firm to use its imaging services in the trial of a therapy for Huntington’s disease sufferers.
Brain health company Ixico has agreed a £1.2m contract with a US biopharmaceutical firm to use its imaging services in the trial of a therapy for Huntington’s disease sufferers.